DE69935973D1 - Zusammensetzungen mit fusionsproteinen der kinase wee1, nukleotidsequenzen, expressionsysteme und verfahren zu deren verwendung - Google Patents

Zusammensetzungen mit fusionsproteinen der kinase wee1, nukleotidsequenzen, expressionsysteme und verfahren zu deren verwendung

Info

Publication number
DE69935973D1
DE69935973D1 DE69935973T DE69935973T DE69935973D1 DE 69935973 D1 DE69935973 D1 DE 69935973D1 DE 69935973 T DE69935973 T DE 69935973T DE 69935973 T DE69935973 T DE 69935973T DE 69935973 D1 DE69935973 D1 DE 69935973D1
Authority
DE
Germany
Prior art keywords
fusion proteins
compositions
wee1
nucleotide sequences
expression systems
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69935973T
Other languages
English (en)
Other versions
DE69935973T2 (de
Inventor
Paul Russell
Michael N Boddy
Beth Funari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Application granted granted Critical
Publication of DE69935973D1 publication Critical patent/DE69935973D1/de
Publication of DE69935973T2 publication Critical patent/DE69935973T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1085Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C12N9/1088Glutathione transferase (2.5.1.18)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69935973T 1998-03-27 1999-03-26 Zusammensetzungen mit fusionsproteinen der kinase wee1, nukleotidsequenzen, expressionsysteme und verfahren zu deren verwendung Expired - Fee Related DE69935973T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7975298P 1998-03-27 1998-03-27
US79752P 1998-03-27
PCT/US1999/006704 WO1999049061A1 (en) 1998-03-27 1999-03-26 Kinase wee1 fusion protein compositions, nucleotide sequences, expression systems, and methods of use

Publications (2)

Publication Number Publication Date
DE69935973D1 true DE69935973D1 (de) 2007-06-14
DE69935973T2 DE69935973T2 (de) 2008-01-10

Family

ID=22152585

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69935973T Expired - Fee Related DE69935973T2 (de) 1998-03-27 1999-03-26 Zusammensetzungen mit fusionsproteinen der kinase wee1, nukleotidsequenzen, expressionsysteme und verfahren zu deren verwendung

Country Status (10)

Country Link
US (2) US6524850B1 (de)
EP (1) EP1064389B1 (de)
JP (1) JP2002507427A (de)
AT (1) ATE361367T1 (de)
AU (1) AU758623B2 (de)
CA (1) CA2324230A1 (de)
DE (1) DE69935973T2 (de)
DK (1) DK1064389T3 (de)
ES (1) ES2286882T3 (de)
WO (1) WO1999049061A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2389200A (en) 1998-12-23 2000-07-12 Pioneer Hi-Bred International, Inc. Cell cycle nucleic acids, polypeptides and uses thereof
AU2003300076C1 (en) 2002-12-30 2010-03-04 Angiotech International Ag Drug delivery from rapid gelling polymer composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5443962A (en) * 1993-06-04 1995-08-22 Mitotix, Inc. Methods of identifying inhibitors of cdc25 phosphatase

Also Published As

Publication number Publication date
US6524850B1 (en) 2003-02-25
WO1999049061A1 (en) 1999-09-30
US7226754B2 (en) 2007-06-05
JP2002507427A (ja) 2002-03-12
DK1064389T3 (da) 2007-06-25
DE69935973T2 (de) 2008-01-10
ATE361367T1 (de) 2007-05-15
AU758623B2 (en) 2003-03-27
CA2324230A1 (en) 1999-09-30
US20030216563A1 (en) 2003-11-20
EP1064389A1 (de) 2001-01-03
ES2286882T3 (es) 2007-12-01
AU3454299A (en) 1999-10-18
EP1064389B1 (de) 2007-05-02
EP1064389A4 (de) 2002-02-06

Similar Documents

Publication Publication Date Title
DE122010000023I1 (de) IL-1 Rezeptor Fusionproteine verwendet als Antagoniste und Verfahren zu deren Verwendung und Hertstellung.
DE69434614D1 (de) Cdn apoptosis modulierende proteine, sie kodierende dns und verfahren zu ihrer verwendung
ATE536372T1 (de) Verfahren zur hoher expression der aktiven form von lymphotoxin-beta-rezeptor-immunglobulin fusionsproteinen, und deren reinigung
HUP0100813A2 (hu) Ellenanyag-alapú fúziós proteinek keringési féléletidejének meghosszabbítása
BR9912545A (pt) ácidos nucleicos codificando um receptorcopulado a proteìna g envolvido em transduçãosensorial
DE69623014D1 (de) Verfahren zur identifizierung und isolierung von einem molekül und von diesem erkannte moleküle
ATE374247T1 (de) Thymidinkinase mutanten und fusionproteine mit thymidinkinase und guanylatekinase aktivitäten
ATE469981T1 (de) Tests auf proteinkinasen mit fluoreszierenden proteinsubstraten
BR9912455A (pt) ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória
ATE325344T1 (de) Zielsequenzen für synthetische moleküle und verfahren für deren verwendung
DE60319369D1 (de) Nukleinsäuren, polypeptide und verfahren zur modulierung von apoptosis
ATE489478T1 (de) Nukleinsäuren, polypeptide und verfahren zur apoptosemodulation
ATE223491T1 (de) Verfahren zur reinigung von biomolekül- oder proteinkomplexen
ATE361367T1 (de) Zusammensetzungen mit fusionsproteinen der kinase wee1, nukleotidsequenzen, expressionsysteme und verfahren zu deren verwendung
ES2128048T3 (es) Adn codificante de proteinas de resistencia a cai, y sus aplicaciones.
DE50014875D1 (de) Verfahren zum herstellen eines rekombinanten proteins
DE69426018T2 (de) Ein mutiertes crp-protein und verfahren und mittel zu dessen herstellung und verwendung
SE9901115D0 (sv) Nucleotide sequences

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee